ABTA Seeks Novel Ideas to Award Its Research Discovery Grants

Printer Friendly

August 23, 2011 - Chicago, Illinois

Researchers now have an opportunity to receive grant funds for proof of concept studies and other explorations that push the boundaries of traditional brain tumor diagnostic or treatment approaches. The American Brain Tumor Association is currently accepting letters of intent for its Discovery Grants.

“Our goal is to improve medical outcomes for the 600,000 Americans living with a brain tumor diagnosis,” said ABTA Research Director Deneen Hesser.

The Scientist recently applauded the Discovery Grant program, placing it with the Gates Foundation Grand Challenges and NIH New Innovator Awards as unique, high-impact, ‘high-risk’ research alternatives.

Concepts presented in Discovery Grant projects can involve any type of brain tumor, including primary, metastatic, adult and pediatric. One of four ABTA research funding programs, the Discovery Grant program welcomes ideas originating in non-biology fields such as mathematics, physics, and biophysics.

Letters of Intent (LOI) for American Brain Tumor Association (ABTA) Discovery Grants are due October 3, 2011.

The ABTA Discovery Grants support high risk/high impact projects that have the potential to change current diagnostic or treatment paradigms for either adult or pediatric brain tumors. The ABTA seeks proposals addressing all types of brain tumors, benign or malignant, primary or secondary. Investigators from sciences outside traditional tumor biology fields are encouraged to apply.

This program offers one-year grants not to exceed $50,000 each in direct costs.

For grant details and LOI instructions, visit the ABTA Funding Opportunities page at the ABTA website.

Grant questions can be directed to Alex Sierra, Research Project Assistant, at grants@abta.org. LOIs must be submitted in PDF format to grants(at)abta(dot)org.


Headquartered in Chicago, the American Brain Tumor Association was the first national organization committed to funding brain tumor research and providing compassionate outreach to patients and caregivers coping with a brain tumor diagnosis. For nearly 40 years, the association has funded researchers working toward breakthroughs in brain tumor diagnosis and treatment. Through its dedicated team of licensed healthcare professionals, the ABTA provides brain tumor information and education for patients, families and healthcare professionals. The American Brain Tumor Association is a federally registered 501(c)3 charity that consistently earns high marks from the nation’s charity ranking organizations. For more information, visit http://www.abta.org.